Select Publications
Books
2009, Hepatitis C: An Expanding Perspective, Dore GJ; Dore G; Lloyd AROLA, (eds.), IP Communications, East Hawthorn
Book Chapters
2022, 'Chronic fatigue and postinfective fatigue syndromes', in Clinical Virology: Third Edition, pp. 371 - 383, http://dx.doi.org/10.1128/9781555815981.ch17
,2021, 'Drought and Q fever: The association between trends in the incidence of infection and rainfall in rural Australia', in The Encyclopedia of Bacteriology Research Developments, pp. 1975 - 1988
,2018, 'Immunopathogenesis of HIV Coinfections', in Encyclopedia of AIDS, Springer New York, pp. 1083 - 1096, http://dx.doi.org/10.1007/978-1-4939-7101-5_179
,2017, 'Drought and q fever: The association between trends in the incidence of infection and rainfall in rural australia', in The Principles and Practice of Q Fever: The One Health Paradigm, pp. 301 - 315
,2017, 'Chronic Fatigue and Postinfective Fatigue Syndromes', in Clinical Virology, Fourth Edition, American Society for Microbiology, pp. 373 - 384, http://dx.doi.org/10.1128/9781555819439.ch18
,2016, 'Chronic fatigue and postinfective fatigue syndromes', in Clinical Virology, pp. 371 - 384, http://dx.doi.org/10.1128/9781555819439.ch18
,2014, 'Immunopathogenesis of HIV Coinfections', in Encyclopedia of AIDS, Springer New York, pp. 1 - 15, http://dx.doi.org/10.1007/978-1-4614-9610-6_179-1
,2009, 'Fatigue states following infection', in Yung A; McDonald M; Spelman D; Street A; Johnson P; Sorrell T; McCormack J (ed.), Infectious Diseases A clinical approach, edn. 2, IP Communications, East Hawthorn, Victoria, Australia
,2009, 'Future challenges for hepatitis C', in Dore G; Temple-Smith M; Lloyd A (ed.), Hepatitis C: An Expanding Perspective, edn. 1, IP Communications, East Hawthorn, pp. 433 - 452, http://www.ipcommunications.com.au/
,2005, 'Fatigue states following infection', in Yung A; McDonald M; Spelman D; Street A; Johnson P; Sorrell T; McCormack J (ed.), Infectious Diseases A clinical approach, edn. 2, IP Communications, East Hawthorn, Victoria, Australia, pp. 195 - 204
,1999, 'Chronic fatigue syndrome: current concepts of pathogenesis and treatment', in Current Clinical Topics in Infectious Diseases, edn. Original, Blackwell Science Asia, Carlton, Victoria, pp. 138 - 159
,1999, 'Chronic fatigue syndrome: current concepts of pathogenesis and treatment.', in Current Clinical Topics in Infectious Diseases, Blackwell Science Asia, Carlton, Victoria, pp. 135 - 159
,1997, 'Chronic fatigue syndrome', in Clinical Virology, edn. Original, Churchill Livingstone, New York, pp. 343 - 355
,1997, 'Chronic fatigue syndrome', in Clinical Virology, Churchill Livingstone, New York, pp. 343 - 355
,1997, 'Treatment of chronic fatigue syndrome', in Intravenous Immunoglobulins in Clinical Practice, edn. Original, Marcel Dekker, New York, pp. 267 - 274
,1991, 'The response of patients with chronic fatigue syndrome to intravenously administered gammaglobulin', in Immunotherapy with Intravenous Immunoglobulins, Elsevier, pp. 377 - 386, http://dx.doi.org/10.1016/b978-0-12-370725-3.50039-7
,Journal articles
2024, 'Barriers and advocacy needs for hepatitis C services in prisons: Informing the prisons hepatitis C advocacy toolkit', International Journal of Drug Policy, 126, http://dx.doi.org/10.1016/j.drugpo.2024.104386
,2024, 'People in community corrections are a population with unmet need for viral hepatitis care', eClinicalMedicine, 70, http://dx.doi.org/10.1016/j.eclinm.2024.102548
,2024, 'Reply to: “ ‘One-stop-shop’ point-of-care hepatitis C RNA testing intervention in the prison – some issues”', Journal of Hepatology, 80, pp. e107 - e108, http://dx.doi.org/10.1016/j.jhep.2023.10.020
,2024, 'Scale-up of Direct-Acting Antiviral Treatment in Prisons Is Both Cost-effective and Key to Hepatitis C Virus Elimination', Open Forum Infectious Diseases, 11, http://dx.doi.org/10.1093/ofid/ofad637
,2024, 'Adjunctive canakinumab reduces peripheral inflammation markers and improves positive symptoms in people with schizophrenia and inflammation: A randomized control trial', Brain, Behavior, and Immunity, 115, pp. 191 - 200, http://dx.doi.org/10.1016/j.bbi.2023.10.012
,2024, 'Characterization of antibody-dependent cellular phagocytosis in patients infected with hepatitis C virus with different clinical outcomes', Journal of Medical Virology, 96, http://dx.doi.org/10.1002/jmv.29381
,2024, 'Incidence of hepatitis C virus infection in the prison setting: The SToP-C study', Journal of Viral Hepatitis, 31, pp. 21 - 34, http://dx.doi.org/10.1111/jvh.13895
,2024, 'Preparing correctional settings for the next pandemic: a modeling study of COVID-19 outbreaks in two high-income countries', Frontiers in Public Health, 12, http://dx.doi.org/10.3389/fpubh.2024.1279572
,2024, 'Trends in intravenous immunoglobulin use in New South Wales, Australia', Internal Medicine Journal, 54, pp. 149 - 156, http://dx.doi.org/10.1111/imj.16175
,2023, 'Anomalies in the review process and interpretation of the evidence in the NICE guideline for chronic fatigue syndrome and myalgic encephalomyelitis', Journal of Neurology, Neurosurgery and Psychiatry, 94, pp. 1056 - 1063, http://dx.doi.org/10.1136/jnnp-2022-330463
,2023, 'Early biomarkers for prediction of severe manifestations of dengue fever: a systematic review and a meta-analysis', Scientific Reports, 13, pp. 17485, http://dx.doi.org/10.1038/s41598-023-44559-9
,2023, 'FHL1 promotes chikungunya and o’nyong-nyong virus infection and pathogenesis with implications for alphavirus vaccine design', Nature Communications, 14, http://dx.doi.org/10.1038/s41467-023-42330-2
,2023, 'eLearning improves allied health professionals' knowledge and confidence to manage medically unexplained chronic fatigue states: A randomized controlled trial', Journal of Psychosomatic Research, 173, pp. 111462, http://dx.doi.org/10.1016/j.jpsychores.2023.111462
,2023, 'A ‘one-stop-shop’ point-of-care hepatitis C RNA testing intervention to enhance treatment uptake in a reception prison: The PIVOT study', Journal of Hepatology, 79, pp. 635 - 644, http://dx.doi.org/10.1016/j.jhep.2023.04.019
,2023, 'Comparative Longitudinal Serological Study of Anti-SARS-CoV-2 Antibody Profiles in People with COVID-19', Microorganisms, 11, http://dx.doi.org/10.3390/microorganisms11081985
,2023, 'Genomic Surveillance of Recent Dengue Outbreaks in Colombo, Sri Lanka', Viruses, 15, pp. 1408, http://dx.doi.org/10.3390/v15071408
,2023, 'Optimizing point-of-care testing strategies for diagnosis and treatment of hepatitis C virus infection in Australia: a model-based cost-effectiveness analysis', The Lancet Regional Health - Western Pacific, 36, http://dx.doi.org/10.1016/j.lanwpc.2023.100750
,2023, 'The path to hepatitis C elimination: who are we leaving behind and why?', Journal of the International AIDS Society, 26, http://dx.doi.org/10.1002/jia2.26136
,2023, 'Reducing barriers to the hepatitis C care cascade in prison via point-of-care RNA testing: a qualitative exploration of men in prison using an integrated framework', Addiction, 118, pp. 1153 - 1160, http://dx.doi.org/10.1111/add.16137
,2023, 'Emergence and antibody evasion of BQ, BA.2.75 and SARS-CoV-2 recombinant sub-lineages in the face of maturing antibody breadth at the population level', eBioMedicine, 90, http://dx.doi.org/10.1016/j.ebiom.2023.104545
,2023, 'Prevalence and Characteristics Associated with Post-COVID-19 Condition among Nonhospitalized Adolescents and Young Adults', JAMA Network Open, 6, pp. E235763, http://dx.doi.org/10.1001/jamanetworkopen.2023.5763
,2023, 'Consensus recommendations on the management of hepatitis C in Australia's prisons', Medical Journal of Australia, 218, pp. 231 - 237, http://dx.doi.org/10.5694/mja2.51854
,2023, 'A national programme to scale-up decentralised hepatitis C point-of-care testing and treatment in Australia', The Lancet Gastroenterology and Hepatology, 8, pp. 204 - 207, http://dx.doi.org/10.1016/S2468-1253(22)00355-7
,2023, 'Prison-based interventions are key to achieving HCV elimination among people who inject drugs in New South Wales, Australia: A modelling study', Liver International, 43, pp. 569 - 579, http://dx.doi.org/10.1111/liv.15469
,2023, 'High activation levels maintained in receptor-binding domain–specific memory B cells in people with severe coronavirus disease 2019', Immunology and Cell Biology, 101, pp. 142 - 155, http://dx.doi.org/10.1111/imcb.12607
,2023, 'A unique cytotoxic CD4+ T cell-signature defines critical COVID-19', Clinical and Translational Immunology, 12, http://dx.doi.org/10.1002/cti2.1463
,2023, 'Predicting hepatitis B e Antigen seroconversion after pregnancy—The SydPregScore', Liver International, 43, pp. 69 - 76, http://dx.doi.org/10.1111/liv.15372
,2023, 'Recomendaciones para el manejo de la infección por el virus de la hepatitis C entre usuarios de drogas por vía parenteral', International Journal of Drug Policy, 111, http://dx.doi.org/10.1016/j.drugpo.2015.11.011
,2023, 'Recommandations pour la prise en charge de l'infection par le virus de l'hépatite C chez les usagers de drogues par injection', International Journal of Drug Policy, 111, pp. 101669, http://dx.doi.org/10.1016/j.drugpo.2015.11.009
,2023, 'B Cell Signatures and Antibody Imprinting Define HCV Reinfection Outcome', , http://dx.doi.org/10.2139/ssrn.4418620
,2022, 'Effect of prior Zika and dengue virus exposure on the severity of a subsequent dengue infection in adults', Scientific Reports, 12, pp. 17225, http://dx.doi.org/10.1038/s41598-022-22231-y
,2022, 'Identification of human progenitors of exhausted CD8+ T cells associated with elevated IFN-γ response in early phase of viral infection', Nature Communications, 13, http://dx.doi.org/10.1038/s41467-022-35281-7
,2022, 'Peripheral NF-κB dysregulation in people with schizophrenia drives inflammation: putative anti-inflammatory functions of NF-κB kinases', Translational Psychiatry, 12, pp. 21, http://dx.doi.org/10.1038/s41398-021-01764-2
,